Cargando…

SAT-374 Adrenal Incidentaloma Management: Development of a Cost-Effectiveness Tool

We developed a cost-effectiveness tool “the Adrenal Incidentaloma Intervention Cost Assessment Tool (AI(2)CAT)”. We developed a novel web-based, electronic Adrenal Incidentaloma Management System (eAIMS). We conducted time & motion study utilising the estimated time managing an individual AI cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Fahmy W. F., Issa, Basil, Lea, Simon, George, Cherian, Golash, Anourag, Firn, Mike, Sim, Julius, Xydopoulos, Georgios, Fordham, Richard, Fryer, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552289/
http://dx.doi.org/10.1210/js.2019-SAT-374
_version_ 1783424569000853504
author Hanna, Fahmy W. F.
Issa, Basil
Lea, Simon
George, Cherian
Golash, Anourag
Firn, Mike
Sim, Julius
Xydopoulos, Georgios
Fordham, Richard
Fryer, Anthony
author_facet Hanna, Fahmy W. F.
Issa, Basil
Lea, Simon
George, Cherian
Golash, Anourag
Firn, Mike
Sim, Julius
Xydopoulos, Georgios
Fordham, Richard
Fryer, Anthony
author_sort Hanna, Fahmy W. F.
collection PubMed
description We developed a cost-effectiveness tool “the Adrenal Incidentaloma Intervention Cost Assessment Tool (AI(2)CAT)”. We developed a novel web-based, electronic Adrenal Incidentaloma Management System (eAIMS). We conducted time & motion study utilising the estimated time managing an individual AI case. This was undertaken for different phases of our work: (i) pre-intervention, (ii) The implementation of case prioritisation strategy + utilisation of eAIMS and (iii) future proactive case identification and streamlining into low- and high-risk groups. Projecting our unit’s case load to a UK-wide context, there could be 50,000 new cases PA/year. Utilising the AI2CAT tool and the time and motion analysis data, demonstrated that introducing the eAIMS system in combination with the MDT prioritisation process (Phase 2) reduced the number of tasks required in the AI management pathway. This resulted in a reduction in the hands-on total time taken (from AI identification to MDT decision) by 48.6%. Utilising standardised staff costs, hands-on time was reduced by 28.2% of total costs/patient. Conclusion: We have developed an electronic management system for AI, together with a cost-effectiveness tool to measure the potential cost implications. The combined approach of using the eAIMS system together with a prioritisation strategy resulted in reduced staff hands-on time and cost per case.
format Online
Article
Text
id pubmed-6552289
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65522892019-06-13 SAT-374 Adrenal Incidentaloma Management: Development of a Cost-Effectiveness Tool Hanna, Fahmy W. F. Issa, Basil Lea, Simon George, Cherian Golash, Anourag Firn, Mike Sim, Julius Xydopoulos, Georgios Fordham, Richard Fryer, Anthony J Endocr Soc Adrenal We developed a cost-effectiveness tool “the Adrenal Incidentaloma Intervention Cost Assessment Tool (AI(2)CAT)”. We developed a novel web-based, electronic Adrenal Incidentaloma Management System (eAIMS). We conducted time & motion study utilising the estimated time managing an individual AI case. This was undertaken for different phases of our work: (i) pre-intervention, (ii) The implementation of case prioritisation strategy + utilisation of eAIMS and (iii) future proactive case identification and streamlining into low- and high-risk groups. Projecting our unit’s case load to a UK-wide context, there could be 50,000 new cases PA/year. Utilising the AI2CAT tool and the time and motion analysis data, demonstrated that introducing the eAIMS system in combination with the MDT prioritisation process (Phase 2) reduced the number of tasks required in the AI management pathway. This resulted in a reduction in the hands-on total time taken (from AI identification to MDT decision) by 48.6%. Utilising standardised staff costs, hands-on time was reduced by 28.2% of total costs/patient. Conclusion: We have developed an electronic management system for AI, together with a cost-effectiveness tool to measure the potential cost implications. The combined approach of using the eAIMS system together with a prioritisation strategy resulted in reduced staff hands-on time and cost per case. Endocrine Society 2019-04-30 /pmc/articles/PMC6552289/ http://dx.doi.org/10.1210/js.2019-SAT-374 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Adrenal
Hanna, Fahmy W. F.
Issa, Basil
Lea, Simon
George, Cherian
Golash, Anourag
Firn, Mike
Sim, Julius
Xydopoulos, Georgios
Fordham, Richard
Fryer, Anthony
SAT-374 Adrenal Incidentaloma Management: Development of a Cost-Effectiveness Tool
title SAT-374 Adrenal Incidentaloma Management: Development of a Cost-Effectiveness Tool
title_full SAT-374 Adrenal Incidentaloma Management: Development of a Cost-Effectiveness Tool
title_fullStr SAT-374 Adrenal Incidentaloma Management: Development of a Cost-Effectiveness Tool
title_full_unstemmed SAT-374 Adrenal Incidentaloma Management: Development of a Cost-Effectiveness Tool
title_short SAT-374 Adrenal Incidentaloma Management: Development of a Cost-Effectiveness Tool
title_sort sat-374 adrenal incidentaloma management: development of a cost-effectiveness tool
topic Adrenal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552289/
http://dx.doi.org/10.1210/js.2019-SAT-374
work_keys_str_mv AT hannafahmywf sat374adrenalincidentalomamanagementdevelopmentofacosteffectivenesstool
AT issabasil sat374adrenalincidentalomamanagementdevelopmentofacosteffectivenesstool
AT leasimon sat374adrenalincidentalomamanagementdevelopmentofacosteffectivenesstool
AT georgecherian sat374adrenalincidentalomamanagementdevelopmentofacosteffectivenesstool
AT golashanourag sat374adrenalincidentalomamanagementdevelopmentofacosteffectivenesstool
AT firnmike sat374adrenalincidentalomamanagementdevelopmentofacosteffectivenesstool
AT simjulius sat374adrenalincidentalomamanagementdevelopmentofacosteffectivenesstool
AT xydopoulosgeorgios sat374adrenalincidentalomamanagementdevelopmentofacosteffectivenesstool
AT fordhamrichard sat374adrenalincidentalomamanagementdevelopmentofacosteffectivenesstool
AT fryeranthony sat374adrenalincidentalomamanagementdevelopmentofacosteffectivenesstool